Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aohua Endoscopy

Explore full profile

Shanghai flexible video endoscopy systems (STAR 688212)

Minhang District, ChinaFounded 1994Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2026
Revenue $100–500M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Aohua Endoscopy and the history behind them.

About Aohua Endoscopy

Founded in 1994 and headquartered in Shanghai, Aohua Photoelectricity Endoscope Co., Ltd. is a medical device company focused on the research, development, production, and sale of video endoscopic equipment and related consumables. The company has established itself as a notable domestic player in China's flexible electronic endoscope market, which it entered at an early stage. A significant milestone in Aohua's journey was its initial public offering on the Shanghai Stock Exchange's STAR Market on November 15, 2021, which raised ¥750 million.

The business operates by manufacturing and selling a comprehensive portfolio of endoscopy products. Its client base consists of hospitals and clinics, with products used in various clinical departments, including gastroenterology, pulmonology, ENT, gynecology, and emergency medicine. Revenue is generated from the sale of endoscope equipment, endoscopic diagnosis and treatment consumables, and maintenance services. For the full year ended December 31, 2023, the company reported sales of CNY 678.08 million. Aohua has a global marketing network that spans over 80 countries and has established R&D centers and production bases in China and an international manufacturing base in Munich.

Aohua's product lineup ranges from standard to high-definition video endoscopy systems, such as the AQ series, which feature optical image enhancement technology. The company launched China's first video endoscopy system in 2005 and has since introduced progressively advanced systems, including HD and 4K ultra-high-definition models. Beyond the main endoscopy systems, the company provides peripheral devices, surgical consumables like brushes and forceps, and also serves the veterinary market with specialized endoscopy systems. This strategy allows Aohua to offer an integrated solution for endoscopic procedures.

Source: Dealroom company data

At a glance

Status
Operational
Founded
1994
Headquarters
Minhang District, China
Employees
107
Open positions
1
Dealroom signal
40.7/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Health Diagnostics, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company
Capital deployed
—
Preferred round
Unknown

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Nov 2021 $117M $800M Undisclosed ↗
SERIES DOther financing Sep 2018 $44M $175M LYFE Capital —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Aohua Endoscopy website traffic

Latest recorded traffic for Aohua Endoscopy is 1.4K monthly website visits, up 483.3% over the last three months. Aohua Endoscopy's team declined 3.6% over the past year.

Latest monthly visits1.4K 3-month web change+483.3% 1-year team growth-3.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Gemina LabsDeveloped and patented a transformative bio-chemistry that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals Calgary, Canada Operational 5 $2.4M $1.9M
LUMINELLE 360An innovative femtech solution offering convenient, cost-effective office Hysteroscopy and Cystoscopy procedures Raleigh, United States Acquired
AccexibleDeveloping a speech analysis platform based on AI models to early detect diseases as dementia, Parkinson, and coronary disease Bilbao, Spain Operational
EarlySightDeveloping a medical device to help doctors detect and treat eye diseases at an early-stage thanks to precise measurement of the eye condition Geneva, Switzerland Operational
OiviPreventing blindness among diabetes patients by deploying an AI-camera for automated diagnosis of retinal diseases Oslo, Norway Operational
Zio HealthPocket-sized biosensor technology for point-of-care molecular testing London, United Kingdom Operational
RTsafeEnsures safety and efficiency of radiation oncology treatments of cancer patients, in a personalized (patient-specific) manner Athens, Greece Operational
iCellate MedicalDevelops products in the areas of cancer diagnosis, based on detection and analyses of circulating tumour cells (CTC), circulating tumour DNA (ctDNA) and germline DNA Solna kommun, Sweden Operational
Showing 8 of the closest matchesCompare every metric →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later2 investors entered at this stage

Other known investors1 additional known investor

Employees 107 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
15 countries with
team presence
🇨🇳 China70.3%
🇧🇷 Brazil4.7%
🇮🇳 India4.7%
🇩🇪 Germany3.1%
🇦🇪 United Arab Emirates1.6%
Top 5 of 15 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aohua Endoscopy on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aohua Endoscopy’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.